Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.

Pneumolysin is an important virulence factor of the human pathogen Streptococcus pneumoniae. Sequence analysis of the ply gene from 121 clinical isolates of S. pneumoniae uncovered a number of alleles. Twenty-two strains were chosen for further analysis, and 14 protein alleles were discovered. Five of these had been reported previously, and the remaining 9 were novel. Cell lysates were used to determine the specific hemolytic activities of the pneumolysin proteins. Six strains showed no hemolytic activity, and the remaining 16 were hemolytic, to varying degrees. We report that the nonhemolytic allele reported previously in serotype 1, sequence type (ST) 306 isolates is also present in a number of pneumococcal isolates of serotype 8 that belong to the ST53 lineage. Serotype 1 and 8 pneumococci are known to be associated with outbreaks of invasive disease. The nonhemolytic pneumolysin allele is therefore associated with the dominant clones of outbreak-associated serotypes of S. pneumoniae.

[1]  T. Mitchell,et al.  Identification of a Secreted Cholesterol-Dependent Cytolysin (Mitilysin) from Streptococcus mitis , 2006, Journal of bacteriology.

[2]  K. Fennie,et al.  Variation in the Presence of Neuraminidase Genes among Streptococcus pneumoniae Isolates with Identical Sequence Types , 2006, Infection and Immunity.

[3]  S. Clarke,et al.  Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin , 2006, Journal of Clinical Microbiology.

[4]  C. Dowson,et al.  NanA, a Neuraminidase from Streptococcus pneumoniae, Shows High Levels of Sequence Diversity, at Least in Part through Recombination with Streptococcus oralis , 2005, Journal of bacteriology.

[5]  G. Pluschke,et al.  An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. , 2005, The Journal of infectious diseases.

[6]  R. George,et al.  Multilocus Sequence Typing Directly on DNA from Clinical Samples and a Cultured Isolate To Investigate Linked Fatal Pneumococcal Disease in Residents of a Shelter for Homeless Men , 2005, Journal of Clinical Microbiology.

[7]  S. Clarke,et al.  Whole gene pneumolysin PCR can be used as a diagnostic assay but cannot predict serotype , 2004, British journal of biomedical science.

[8]  B. Spratt,et al.  Geographic Distribution and Clonal Diversity of Streptococcus pneumoniae Serotype 1 Isolates , 2003, Journal of Clinical Microbiology.

[9]  P. Andrew,et al.  Streptococcus pneumoniae Damages the Ciliated Ependyma of the Brain during Meningitis , 2003, Infection and Immunity.

[10]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Ronald Anderson,et al.  Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. , 2002, The Journal of infectious diseases.

[12]  G. Pozzi,et al.  Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. , 2002, Gene.

[13]  S. Salzberg,et al.  Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae , 2001, Science.

[14]  J. R. de los Toyos,et al.  A SPECIFIC AND ULTRASENSITIVE CHEMILUMINESCENT SANDWICH ELISA TEST FOR THE DETECTION AND QUANTITATION OF PNEUMOLYSIN , 2001, Journal of immunoassay & immunochemistry.

[15]  K. Kim,et al.  Pneumolysin Is the Main Inducer of Cytotoxicity to Brain Microvascular Endothelial Cells Caused by Streptococcus pneumoniae , 2001, Infection and Immunity.

[16]  D. Crook,et al.  Invasive pneumococcal disease in England and Wales: vaccination implications. , 2001, The Journal of infectious diseases.

[17]  R. Nau,et al.  Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae , 2000, Clinical and experimental immunology.

[18]  P. Andrew,et al.  Effect of Pneumolysin on Rat Brain Ciliary Function: Comparison of Brain Slices with Cultured Ependymal Cells , 2000, Pediatric Research.

[19]  R. Dagan,et al.  An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  D. Briles,et al.  The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia , 1999, Infection and Immunity.

[21]  M. Gentry,et al.  Role of Pneumolysin’s Complement-Activating Activity during Pneumococcal Bacteremia in Cirrhotic Rats , 1999, Infection and Immunity.

[22]  B. Spratt,et al.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. , 1998, Microbiology.

[23]  Samuel L. Moore,et al.  Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. , 1998, Vaccine.

[24]  Ernesto García,et al.  Characterization of IS1515, a Functional Insertion Sequence in Streptococcus pneumoniae , 1998, Journal of bacteriology.

[25]  J. Paton,et al.  Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. , 1996, Microbial pathogenesis.

[26]  J. R. de los Toyos,et al.  Functional analysis of pneumolysin by use of monoclonal antibodies , 1996, Infection and immunity.

[27]  A. Lindberg,et al.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines , 1995, Infection and immunity.

[28]  P. Andrew,et al.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae , 1994, Infection and immunity.

[29]  B. Spratt,et al.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics. , 1994, Trends in microbiology.

[30]  J. Hanna,et al.  An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia , 1993, The Medical journal of Australia.

[31]  J. Zhou,et al.  Horizontal transfer of multiple penicillin‐binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae , 1991, Molecular microbiology.

[32]  B. Dautzenberg,et al.  An outbreak of pneumococcal pneumonia in two men's shelters. , 1991, Chest.

[33]  Timothy J. Mitchell,et al.  Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2 , 1990, Nucleic Acids Res..

[34]  G. Boulnois,et al.  Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae , 1987, Infection and immunity.

[35]  R. Möllby,et al.  Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin) , 1987, Journal of clinical microbiology.

[36]  M. Granström,et al.  Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin) , 1987, Journal of clinical microbiology.

[37]  K. Gage,et al.  Type 8 Pneumococcal Pneumonia: An Outbreak on an Oncology Ward , 1985, Southern medical journal.

[38]  Curtis N. James,et al.  Activation of human complement by the pneumococcal toxin pneumolysin , 1984, Infection and immunity.

[39]  W. R. Mccabe,et al.  An outbreak of type 1 pneumococcal pneumonia in a men's shelter. , 1980, JAMA.